The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review.

Asthma / epidemiology COVID-19 / epidemiology Cost-Benefit Analysis Humans Pandemics Telemedicine
Access to care Allergy Asthma Asthma biologics Asthma cost-effectiveness COVID-19 Health care disparities Health equity Telemedicine

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
08 2022
Historique:
received: 10 07 2021
revised: 25 03 2022
accepted: 12 04 2022
pubmed: 8 5 2022
medline: 17 8 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

Inconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely affect asthma. The purpose of this review is to identify health disparities associated with access to care for asthma, and cost-effectiveness of therapies and interventions addressing this health disparity. A narrative systematic review was undertaken using MeSH searches of English language articles published in CINAHL, Scopus, or PubMed. A total of 725 articles were identified. Barriers recognized from the literature included access to diagnostic spirometry, access to specialists, medication formulary restrictions, and issues leading to medical nonadherence. Telemedicine, school-based health care interventions, digital applications, and non-office-based digital spirometry could be used to address these gaps in access to asthma care while potentially being cost-effective. With the widespread adoption of telemedicine because of the pandemic, and adoption of other mobile services, we now have potential tools that can increase access to asthma care, which can help address this health care inequity. Evidence is limited, but favorable, that some of these tools may be cost-effective.

Sections du résumé

BACKGROUND
Inconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely affect asthma.
OBJECTIVE
The purpose of this review is to identify health disparities associated with access to care for asthma, and cost-effectiveness of therapies and interventions addressing this health disparity.
METHODS
A narrative systematic review was undertaken using MeSH searches of English language articles published in CINAHL, Scopus, or PubMed.
RESULTS
A total of 725 articles were identified. Barriers recognized from the literature included access to diagnostic spirometry, access to specialists, medication formulary restrictions, and issues leading to medical nonadherence. Telemedicine, school-based health care interventions, digital applications, and non-office-based digital spirometry could be used to address these gaps in access to asthma care while potentially being cost-effective.
CONCLUSION
With the widespread adoption of telemedicine because of the pandemic, and adoption of other mobile services, we now have potential tools that can increase access to asthma care, which can help address this health care inequity. Evidence is limited, but favorable, that some of these tools may be cost-effective.

Identifiants

DOI: 10.1016/j.jaip.2022.04.025 PMID: 35525532 PMC: PMC9353043
pubmed: 35525532
pii: S2213-2198(22)00433-0
doi: 10.1016/j.jaip.2022.04.025
pmc: PMC9353043
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2109-2116

Informations de copyright

Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

J Allergy Clin Immunol Pract. 2020 Sep;8(8):2461-2473.e3
pubmed: 32603900
Clin Transl Allergy. 2020 Jun 18;10:23
pubmed: 32566128
World Allergy Organ J. 2018 Dec 3;11(1):28
pubmed: 30524644
J Allergy Clin Immunol. 2020 Dec;146(6):1217-1270
pubmed: 33280709
Ann Allergy Asthma Immunol. 2019 Apr;122(4):367-372
pubmed: 30703438
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2574-2579
pubmed: 31425835
J Allergy Clin Immunol Pract. 2021 Feb;9(2):663-669
pubmed: 33317817
Lung. 2015 Aug;193(4):505-12
pubmed: 25921015
J Allergy Clin Immunol. 2020 May;145(5):1367-1377.e4
pubmed: 31837372
Med Care. 2004 Mar;42(3):200-9
pubmed: 15076819
JMIR Pediatr Parent. 2021 Feb 24;4(1):e22696
pubmed: 33556030
Chest. 2020 Dec;158(6):2502-2510
pubmed: 32652095
Chest. 2012 May;141(5):1190-1196
pubmed: 22030804
BMC Int Health Hum Rights. 2013 Mar 08;13:15
pubmed: 23497027
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2377-2398
pubmed: 33652136
Pulm Ther. 2021 Jun;7(1):189-201
pubmed: 33713011
Ann Allergy Asthma Immunol. 2010 Oct;105(4):274-281
pubmed: 20934626
Ann Am Thorac Soc. 2018 Mar;15(3):348-356
pubmed: 29323930
Am J Manag Care. 2017 Apr 1;23(4):e120-e126
pubmed: 28554211
Telemed J E Health. 2015 Feb;21(2):81-5
pubmed: 25474190
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2524-2532
pubmed: 31706484
Respiration. 2014;88(4):346-52
pubmed: 25195762
Laryngoscope. 2021 Jan;131(1):E70-E75
pubmed: 32249932
Chest. 1999 Oct;116(4 Suppl 1):145S-154S
pubmed: 10532476
Cochrane Database Syst Rev. 2017 Apr 18;4:CD012226
pubmed: 28417456
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Sensors (Basel). 2019 May 31;19(11):
pubmed: 31159155
J Sch Health. 2001 Jan;71(1):9-16
pubmed: 11221541
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1107-1117.e2
pubmed: 33069886
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3091-3097.e1
pubmed: 33864928
J Allergy Clin Immunol. 2021 May;147(5):1579-1593
pubmed: 33713767
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
J Asthma. 2022 Apr;59(4):697-711
pubmed: 33435775
J Allergy Clin Immunol. 2011 Feb;127(2):363-369.e1-3
pubmed: 21281868
J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138
pubmed: 17983880
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
Ann Allergy Asthma Immunol. 2018 Apr;120(4):395-400.e1
pubmed: 29452259
N Engl J Med. 1992 Mar 26;326(13):862-6
pubmed: 1542323
J Allergy Clin Immunol. 2011 Jan;127(1):145-52
pubmed: 21211649
Chest. 2017 Feb;151(2):249-251
pubmed: 28183482
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Arch Pediatr Adolesc Med. 2003 Feb;157(2):125-9
pubmed: 12580680
J Adolesc Health. 2005 Oct;37(4):266-74
pubmed: 16182136
JAMA Pediatr. 2018 Mar 5;172(3):e174938
pubmed: 29309483
J Asthma. 2009 May;46(4):392-8
pubmed: 19484676
Curr Opin Allergy Clin Immunol. 2004 Jun;4(3):191-5
pubmed: 15126940
J Allergy Clin Immunol. 2015 Sep;136(3):610-8
pubmed: 25794659
Chest. 2017 Jan;151(1):17-20
pubmed: 27746204
J Pediatr. 2021 Jul;234:128-133.e1
pubmed: 33711287
Eur Respir J. 2018 Apr 4;51(4):
pubmed: 29519922
J Pediatr Nurs. 2021 Jul-Aug;59:143-150
pubmed: 33887684
Curr Opin Pulm Med. 2020 Jan;26(1):47-55
pubmed: 31644439
Ann Allergy Asthma Immunol. 2018 Apr;120(4):401-408
pubmed: 29471032
Am J Public Health. 2010 Sep;100(9):1617-23
pubmed: 20634450
Am J Manag Care. 2020 Feb;26(2):75-79
pubmed: 32059095
Am J Prev Med. 2016 Jul;51(1):114-26
pubmed: 27320215
Immunol Allergy Clin North Am. 2019 May;39(2):191-204
pubmed: 30954170
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2535-2543
pubmed: 31706485
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1102-1112
pubmed: 31166782

Auteurs

Christopher D Codispoti (CD)

Department of Internal Medicine, Division of Allergy and Clinical Immunology, Rush University Medical Center, Chicago, Ill; Department of Pediatrics, Rush University Medical Center, Chicago, Ill. Electronic address: Christopher_D_Codispoti@rush.edu.

Matthew Greenhawt (M)

Section of Allergy and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.

John Oppenheimer (J)

UMDNJ Rutgers University School of Medicine, Newark, NJ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › The Role of Access and Cost-Effectiveness in...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › The Role of Access and Cost-Effectiveness in...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › The Role of Access and Cost-Effectiveness in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Role of Access and Cost-Effectiveness in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › The Role of Access and Cost-Effectiveness in...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Télémédecine › The Role of Access and Cost-Effectiveness in...